Dongmin (Eugene) Bang


Untitled

With a dual background in pharmacy and computational biology, I focus on integrating pharmacological insight with machine learning to tackle a core challenge in drug discovery and precision medicine: extracting actionable knowledge from complex, high-dimensional, and often sparse biomedical data.

My research centers on developing knowledge-aware computational frameworks—including patient-specific gene regulatory modeling, graph-based learning, and multi-modal molecular representation—to improve therapeutic prediction, compound prioritization, and drug-likeness evaluation. These efforts prioritize model interpretability, translational generalizability, and the principled incorporation of domain knowledge into data-driven systems.

EDUCATION


2021- Ph.D. Candidate in Bioinformatics, Seoul National University, Seoul, Korea

(Advisor: Sun Kim)

2015- Pharm.D., Chung-Ang University, Seoul, Korea

2012- B.S.E. Student in Architectural Engineering, Hanyang University, Seoul, Korea

PUBLICATIONS & PROCEEDINGS


<aside> 🎓 Google scholar page

</aside>

(: Equal contributions)*

  1. D Bang, I Sung, Y Piao, S Lee, S Kim. “Predicting Drug-likeness via Biomedical Knowledge Alignment and EM-like One-Class Boundary Optimization.” ICML 2025 (Accepted for poster presentation)
  2. D Bang*, J Kim*, H Song, S Kim. “ADME-Drug-Likeness: Enriching Molecular Foundation Models via Pharmacokinetics-Guided Multi-Task Learning for Drug-likeness Prediction.ISMB/ECCB 2025 (Accepted)
  3. Y Kim*, D Bang*, B Koo, J Yi, C Cho, J Choi, S Kim. “MixingDTA: Improved Drug-Target Affinity Prediction by Extending Mixup with Guilt-By-Association.ISMB/ECCB 2025 (Accepted)
  4. S Ha*, D Bang*, S Kim. “FATE-Tox: Fragment Attention Transformer for E(3)-Equivariant Multi-Organ Toxicity Prediction.Journal of Cheminformatics (May, 2025)
  5. I Sung*, SS Lee*, D Bang, J Yi, S Kim, SH Lee. “MDTR: A Knowledge-Guided Interpretable Representation for Quantifying Liver Toxicity at Transcriptomic Level.” Frontiers in Pharmacology (January, 2025)